Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma

被引:40
作者
Tang, Rong [1 ,2 ,3 ,4 ]
Liu, Xiaomeng [1 ,2 ,3 ,4 ]
Liang, Chen [1 ,2 ,3 ,4 ]
Hua, Jie [1 ,2 ,3 ,4 ]
Xu, Jin [1 ,2 ,3 ,4 ]
Wang, Wei [1 ,2 ,3 ,4 ]
Meng, Qingcai [1 ,2 ,3 ,4 ]
Liu, Jiang [1 ,2 ,3 ,4 ]
Zhang, Bo [1 ,2 ,3 ,4 ]
Yu, Xianjun [1 ,2 ,3 ,4 ]
Shi, Si [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghal Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
基金
美国国家科学基金会; 中国国家自然科学基金;
关键词
single cell sequencing; immune microenvironment; pancreatic cancer; prognosis; tumor immune; CANCER; CELLS; HETEROGENEITY; EXPRESSION; TISSUE;
D O I
10.3389/fimmu.2021.648917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor microenvironment, such as immune checkpoint inhibitors, have shown promising efficacy for some tumors, few of them significantly prolong the survival of patients with PDAC due to insufficient knowledge on the tumor microenvironment. Methods: A single-cell RNA sequencing (scRNA-seq) dataset and seven PDAC cohorts with complete clinical and bulk sequencing data were collected for bioinformatics analysis. The relative proportions of each cell type were estimated using the gene set variation analysis (GSVA) algorithm based on the signatures identified by scRNA-seq or previous literature. Results: A meta-analysis of 883 PDAC patients showed that neutrophils are associated with worse overall survival (OS) for PDAC, while CD8+ T cells, CD4+ T cells, and B cells are related to prolonged OS for PDAC, with marginal statistical significance. Seventeen cell categories were identified by clustering analysis based on single-cell sequencing. Among them, CD8+ T cells and NKT cells were universally exhausted by expressing exhaustion-associated molecular markers. Interestingly, signatures of CD8+ T cells and NKT cells predicted prolonged OS for PDAC only in the presence of "targets" for pyroptosis and ferroptosis induction. Moreover, a specific state of T cells with overexpression of ribosome-related proteins was associated with a good prognosis. In addition, the hematopoietic stem cell (HSC)-like signature predicted prolonged OS in PDAC. Weighted gene co-expression network analysis identified 5 hub genes whose downregulation may mediate the observed survival benefits of the HSC-like signature. Moreover, trajectory analysis revealed that myeloid cells evolutionarily consisted of 7 states, and antigen-presenting molecules and complement-associated genes were lost along the pseudotime flow. Consensus clustering based on the differentially expressed genes between two states harboring the longest pseudotime span identified two PDAC groups with prognostic differences, and more infiltrated immune cells and activated immune signatures may account for the survival benefits. Conclusion: This study systematically investigated the prognostic implications of the components of the PDAC tumor microenvironment by integrating single-cell sequencing and bulk sequencing, and future studies are expected to develop novel targeted agents for PDAC treatment.
引用
收藏
页数:15
相关论文
共 58 条
[1]   Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis [J].
Almeida, Luis ;
Dhillon-LaBrooy, Ayesha ;
Castro, Carla N. ;
Adossa, Nigatu ;
Carriche, Guilhermina M. ;
Guderian, Melanie ;
Lippens, Saskia ;
Dennerlein, Sven ;
Hesse, Christina ;
Lambrecht, Bart N. ;
Berod, Luciana ;
Schauser, Leif ;
Blazar, Bruce R. ;
Kalesse, Markus ;
Mueller, Rolf ;
Moita, Luis F. ;
Sparwasser, Tim .
IMMUNITY, 2021, 54 (01) :68-+
[2]   Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage [J].
Aran, Dvir ;
Looney, Agnieszka P. ;
Liu, Leqian ;
Wu, Esther ;
Fong, Valerie ;
Hsu, Austin ;
Chak, Suzanna ;
Naikawadi, Ram P. ;
Wolters, Paul J. ;
Abate, Adam R. ;
Butte, Atul J. ;
Bhattacharya, Mallar .
NATURE IMMUNOLOGY, 2019, 20 (02) :163-+
[3]   xCell: digitally portraying the tissue cellular heterogeneity landscape [J].
Aran, Dvir ;
Hu, Zicheng ;
Butte, Atul J. .
GENOME BIOLOGY, 2017, 18
[4]   Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities [J].
Balachandran, Vinod P. ;
Beatty, Gregory L. ;
Dougan, Stephanie K. .
GASTROENTEROLOGY, 2019, 156 (07) :2056-2072
[5]   Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer [J].
Brooks, Jill M. ;
Menezes, Albert N. ;
Ibrahim, Maha ;
Archer, Lucinda ;
Lal, Neeraj ;
Bagnall, Christopher J. ;
von Zeidler, Sandra V. ;
Valentine, Helen R. ;
Spruce, Rachel J. ;
Batis, Nikolaos ;
Bryant, Jennifer L. ;
Hartley, Margaret ;
Kaul, Baksho ;
Ryan, Gordon B. ;
Bao, Riyue ;
Khattri, Arun ;
Lee, Steven P. ;
Ogbureke, Kalu U. E. ;
Middleton, Gary ;
Tennant, Daniel A. ;
Beggs, Andrew D. ;
Deeks, Jonathan ;
West, Catharine M. L. ;
Cazier, Jean-Baptiste ;
Willcox, Benjamin E. ;
Seiwert, Tanguy Y. ;
Mehanna, Hisham .
CLINICAL CANCER RESEARCH, 2019, 25 (17) :5315-5328
[6]  
Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12
[7]   Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts [J].
Elyada, Ela ;
Bolisetty, Mohan ;
Laise, Pasquale ;
Flynn, William F. ;
Courtois, Elise T. ;
Burkhart, Richard A. ;
Teinor, Jonathan A. ;
Belleau, Pascal ;
Biffi, Giulia ;
Lucito, Matthew S. ;
Sivajothi, Santhosh ;
Armstrong, Todd D. ;
Engle, Dannielle D. ;
Yu, Kenneth H. ;
Hao, Yuan ;
Wolfgang, Christopher L. ;
Park, Youngkyu ;
Preall, Jonathan ;
Jaffee, Elizabeth M. ;
Califano, Andrea ;
Robson, Paul ;
Tuveson, David A. .
CANCER DISCOVERY, 2019, 9 (08) :1102-1123
[8]   Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape [J].
Emens, Leisha A. ;
Ascierto, Paolo A. ;
Darcy, Phillip K. ;
Demaria, Sandra ;
Eggermont, Alexander M. M. ;
Redmond, William L. ;
Seliger, Barbara ;
Marincola, Francesco M. .
EUROPEAN JOURNAL OF CANCER, 2017, 81 :116-129
[9]   Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8 [J].
Fukuhisa, Haruhi ;
Seki, Naohiko ;
Idichi, Tetsuya ;
Kurahara, Hiroshi ;
Yamada, Yasutaka ;
Toda, Hiroko ;
Kita, Yoshiaki ;
Kawasaki, Yota ;
Tanoue, Kiyonori ;
Mataki, Yuko ;
Maemura, Kosei ;
Natsugoe, Shoji .
JOURNAL OF HUMAN GENETICS, 2019, 64 (06) :521-534
[10]   Immunotherapy in colorectal cancer: rationale, challenges and potential [J].
Ganesh, Karuna ;
Stadler, Zsofia K. ;
Cercek, Andrea ;
Mendelsohn, Robin B. ;
Shia, Jinru ;
Segal, Neil H. ;
Diaz, Luis A., Jr. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (06) :361-375